Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Recruiting now · Phase 2 · Has a placebo group
Conditions studied: Hypertension, Acute Severe Hypertension, Hypertensive Emergency, Hypertensive Urgency
In brief
The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.
Key facts
- Study ID
- NCT07511361
- Run by
- Kardigan, Inc.
- People needed
- 140
- Starts
- 2026-06-23
- Expected to finish
- 2027-02-01
- Last updated by the study team
- 2026-07-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Western Nephrology and Metabolic Bone Disease, PC - Arvada — Arvada, Colorado, United States (enrolling)
- Homestead Associates in Research — Homestead, Florida, United States (enrolling)
- Progressive Medical Research — Port Orange, Florida, United States (enrolling)
- Richmond University Medical Center (RUMC) — Staten Island, New York, United States (enrolling)
- Research Innovations, LLC — Beavercreek, Ohio, United States (enrolling)
- Chattanooga Research & Medicine CHARM — Chattanooga, Tennessee, United States (enrolling)
- Laguna Clinical Research Associates — Laredo, Texas, United States (enrolling)
- Baylor Scott and White Research Institute - Temple — Temple, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.